Urogyn B.V. and Medip d.o.o. announce the first six patients treated in Slovenia with Ovalastic – a non-invasive sterilization method that does not require surgery.

We are excited to announce that we have started with a pilot study with Ovalastic in Slovenia and treated six women in the last two days. The first four patients were treated in Maribor University Medical Centre, Maribor (Slovenia) by Drs. Thurkow and Dr. Žegura. The last two patients were treated in Slovenj Gradec General Hospital, Gradec (Slovenia) by Dr. Šavc and Dr. Verdnik Golob. The treatments were all very smooth, partly due to great experience in hysteroscopy of all specialists involved and the fantastic cooperation of the assistants.

The Ovalastic procedure is a non-incisional, non-scarring hysteroscopy procedure for permanent female sterilization with formed-in-place silicone rubber plugs, i.e. occluding the fallopian tubes by mechanical action. In just a few minutes after administration the material solidifies into a soft, flexible and rubbery material that fills up the cavity.

More information regarding the procedure can be found by visiting:


Urogyn acquired by investment company

Urogyn B.V. is very pleased to announce that the Company has been acquired by Arteface Medical Investment limited (AMI) a Hong Kong based investment company.
AMI acquired the entire share capital of Urogyn.

Urogyn has developed unique products in the field of incontinence and sterilization. It’s top product Urolastic™ is a strong candidate to become the first choice in treatment of female stress urinary incontinence while Ovalastic™ is the only safe product in the world for hysteroscopic sterilization.

The acquisition by AMI will allow Urogyn to further expand its sales in Europe and South East Asia says Noes de Vries CEO of Urogyn. It furthermore will open up the way to register our products in the USA.

About Urogyn: Urogyn was founded in 2009 with the ambition of developing new products in the field of urology and gynaecology, based upon a two-component polymer technology. More products are expected to be commercially launched in the near future a.o. for treating faecal incontinence (


First patient in Malaysia successfully treated with Urolastic™ – collaboration between Leader Biomedical and Urogyn yields first results

26 September 2017- AMSTERDAM | MALAYSIA- Urogyn B.V. and Leader Biomedical announce the first patient treated in Malaysia with Urolastic™– an innovative Urinary Stress Incontinence product that is exclusively offered by Leader Biomedical in India and APAC.

We are excited to announce that we have successfully introduced Urolastic™ in Malaysia and treated a female patient suffering from severe Stress Urinary Incontinence (SUI). The patient suffered from the condition, as a result of birth deficiencies and was diagnosed with a short, yet very wide urethra. After previously undergoing a procedure using a bulking agent, the patient went down from using eight pads a day, to five pads a day. Treatment with Urolastic™ earlier this month by Dr. Warren Lo Hwa Loon at Pantai Hospital Kuala Lumpur has improved the patient’s condition, as a result of which she now only uses one pad a day, thus significantly improving her quality of life.

Stress Urinary Incontinence is a disease affecting over 200 million people worldwide. Traditionally, SUI is treated with either a sling or injection of a bulking agent, where a sling procedure is an invasive procedure for the patient and the traditional bulking agents are expensive, as they are only effective for a short period and need to be repeated regularly.

“Patients who would benefit from bulking agent procedure are those that suffered from a failed sling procedure, elderly patients that are happy with a positive effect and incontinence reduction rather than a guaranteed total stop of leakage, and patients that prefer minimally-invasive surgery as opposed to sling procedure surgery” shares Dr. Warren Lo Hwa Loon, Pantai Hospital Kuala Lumpur.

“Urolastic™ is the most effective bulking agent available to patients suffering from SUI. The agent stays at the application site since it is not a fluid in the body, but hardens to form a solid mass. Also, treatment with Urolastic™ is an outpatient procedure in most cases. In addition to being an attractive procedure for the elderly and after failed sling procedures, it also provides an alternative for women who still wish to have children”, adds Dr. Pieter Venema, urologist and experienced Urogyn trainer from the Netherlands.



Urogyn at the 50Plus fair: 19th -23rd September 2017, in Utrecht

On this festive edition of the 50PlusBeurs, Urogyn will be in Hall 9, where visitors will get more information about our treatments for stress urinary incontinence in men and women.

Did you know that unwanted urine loss is a common condition? About one in three women and one in ten men aged 55 and over suffer from this. Undesirable urine loss can have a profound effect on the quality of life, it can bring shame, stress, low self-esteem and create limitations in daily activities.

Do you want to take action without worrying about unwanted urine loss? Then come and check our stand for more information about our treatments.

In 25 years, the 50PlusBeurs with 600 exhibitors and 100,000 visitors, has grown into the world’s largest event for active people over 50. That was different at first edition in The Hague when 96 exhibitors and nearly 9,000 visitors gathered.

On the 50PlusBeurs there is something for everyone, for convenience, the fair is divided into the following themes:

• Holidays
• Leisure
• Living
• Fashion & Beauty
• Health
• Society

In each theme, stands are packed with information and entertainment. There are also workshops and presentations, many performances on podiums with music, fashion shows, cooking demonstrations, dance and theater. Even a rest during your attendance visit? For this reason, there is also a special theme terrace in each hall, where you can sit down and where you can also get food and drink.

With the special Silver Edition, the 50PlusBeurs celebrates this silver anniversary. Especially because of the 25th edition, every visitor receives a Silver Surprise and special activities. For example, the sporty plus is a record attempt, Silver Challenge, which opens the fair with more than 1,000 plus sports. For the happy, caring and fashionable 50plusser there is a Silver Model Election, the final of which will take place during the 50PlusBeurs.
In addition, after the fair there is another Silver Show, a festive performance with singing and cabaret with life as an inexhaustible source of inspiration.

All in all, there is more than enough experience on the biggest fair for active 50 plus people.
Visit our stand at the 25th edition of the 50PlusBeurs from 19th to 23rd September in the Jaarbeurs Utrecht!


Ready for the start of the International Continence Society Meeting in Florence!

We are at the International Continence Society Meeting which is taking place between 12th to 15th September in Florence, Italy. You can find us at booth 34 to learn more about our products for treating stress urinary incontinence, Urolastic and Prolastic.

Meet us there or send us an e-mail at in order to set up a meeting with one of our representatives at the meeting.


The first Urolastic workshop in Czech Republic

On the 1st September 2017, our distributors from Archie Samuel organised the first workshop for Urolastic in Czech Republic.
The workshop took place in Brno, Czech Republic and specialists from five centres were welcomed by Mr. Jiri Deml, Sales Director at Archie Samuel.

The training in the Urolastic procedure was provided by Dr. Mija Blaganje from Ljubljana, Slovenia who is an experienced Urolastic trainer.

More information regarding the availability of our products, Urolastic and Prolastic in Czech Republic can be found at:


We would like to welcome ELVIM LTD to our growing list of distributors

We are very happy to announce that our products will soon be available in Estonia, Latvia and Lithuania thanks to our new distributor, ELVIM LTD.

ELVIM is a GDP licensed medicines wholesaler established in 1992 in Riga, Latvia. ELVIM offers marketing and distribution of medicines and medical devices in the Baltic countries and CIS countries, and provides related services.

Today we welcomed the first two specialists from Latvia at a Urolastic training session in the LangeLand Hospital in Zoetermeer, The Netherlands and we are very hopeful that the first Urolastic procedures in Latvia will be performed before the end of this year.

For more information regarding the availability of Urogyn products in Estonia, Latvia and Lithuania, please contact ELVIM by e-mail: or visit


Learn more about our products by visiting us at booth 34 during the ICS 2017

We are pleased to announce that we will be present at the 47th Annual Meeting of the International Continence Society in Florence, Italy from 12th-15th September 2017.
The meeting is multidisciplinary, bringing together all the professionals working in the field: urologists, gynaecologists, neurologists, physiotherapists, nurses, midwives and basic scientists.
If you are visiting the congress you will be able to learn more about Urogyn and our products at booth number 34.
We will also provide information regarding ongoing clinical trials and training opportunities for specialists.

For more information regarding the congress please visit:


Urogyn on N1, Saturday July 8th at 18:00

Urogyn will be presented in the local TV show ‘NIJMEEGSE KENNIS’ on July 8th on the Dutch channel N1.
Noes de Vries (CEO) will be interviewed about stress urinary incontinence in women by Guido Matthee. The treatment and mechanism of Urolastic will be explained in this interview which will broadcast on the 8th July at 18.00.
An interesting interview for those who are looking for a long-term, non-invasive solution to treat stress incontinence.

Where and when the show is broadcasted:
TV show on N1: Saturday July 8th (18:00h.)
Each hour the show is repeated.
Repetition on N1: Wednesday July 12th (17:00h.)
For those who cannot view the local N1 channel, the show will be available via YouTube from Thursday July 13th. The exact link will be placed on the Urogyn website.


Dr. John Heesakkers from the Radboud University Medical Centre provides training for specialists from Czech Republic

Doctors from Czech Republic attended training at the Radboud University Medical Centre in Nijmegen, Netherlands today.
Two patients were treated by Dr. Heesakkers and doctors were able to view the procedures as well as participate in practical demonstrations given by the Urogyn team.

For more information regarding training in The Netherlands, contact us at


Training in the Urolastic procedure provided for doctors from Croatia and Bosnia and Herzegovina

Thirty doctors from Croatia and Bosnia and Herzegovina attended the Urolastic workshop organized by our distributors Elva Pharma, on the 5th May2017 in Opatija, Croatia.
The training was performed by Dr. Mija Blaganje, urogynaecologist at the Ljubljana University Medical Centre in Slovenia and Dr. Pieter Minnee, urologist at The Lange Land hospital in The Netherlands.
The training program included lectures by our expert practitioners on how to apply Urolastic and the benefits of choosing this procedure for treating patients with stress urinary incontinence. In addition, participants were given practical demonstrations of the Urolastic procedure. We are happy to announce the workshop was a success and are looking forward to future workshops in Croatia.
More information about Urolastic workshops organized in Croatia can be found by contacting our distributors at:


Urolastic workshop in Opatija, Croatia

On the 5th May 2017, 15 doctors from Croatia and Bosnia & Herzegovina will attend a Urolastic training workshop organized by our distributors in Croatia, ELVA Pharma.
The workshop will take place at the Hotel Admiral in Opatija and doctors will be trained in performing the Urolastic procedure. We will post photos and further information following the event.
For more information regarding training and workshops in Croatia, please contact our distributor at


Legacy Medical, our South African distributors, present at the RCOG World Congress 2017 in Cape Town

The RCOG World Congress 2017, now incorporating the ISUOG’s 13th International Symposium, was held at the Cape Town International Convention Centre, South Africa on the 20 – 22 March 2017.
With over 14,000 Fellows and Members worldwide, the Royal College of Obstetricians and Gynaecologists (RCOG) encourages the study and advancement of the science and practice of obstetrics and gynaecology.

Our distributor Legacy Medical attended the congress and showcased our product for treating stress urinary incontinence in women – Urolastic.
Delegates from more than 70 countries , 22 African , attended in what is described as the “Tavern of Seas” setting at the Southern tip of the Continent. It was a true Global event with attendees in the excess of 2000 with many local and world leading.

You can find more information regarding the availability of Urolastic in South Africa by contacting our distributors at or on their website:


We would like to introduce you to our new distributor for Iran, Kimia Behboud Arman

Kimia Behboud Arman is a pharmaceutical company focused on supplying laboratory equipment, medical equipment and pharmaceutical products that match high international standards to universities, hospitals, clinics, doctor’s practices in Iran.

Kimia Behboud Arman seeks to help diagnose and treat disease in a timely fashion, and offer valuable services to customers to help improve healthcare in society.

Urogyn are happy to announce that we have entered into a partnership with Kimia Behboud Arman and are looking forward to have them promote our innovative products for treating stress urinary incontinence, a growing problem that affects millions of people worldwide.

You can learn more about the company by visiting their website:


Training for specialists in The Netherlands or abroad

The first workshop of the year took place at the beginning of January and was organised for international doctors interested in our procedure for treating female stress urinary incontinence.
Dr. Brigida Rocchi from the Ospedale “Treviglio-Caravaggio” in Italy and Prof. Zurab Rainauli, from the University Klinik Tbilisi Cancer Center, in Georgia attended this training session take took place at the LangeLand Hospital in Zoetermeer , The Netherlands.
The goal of our workshops is to offer doctors the opportunity to gain a detailed understanding of our product Urolastic.
The workshops provide a comprehensive description of the product, its performance on recent clinical trials and the opportunity to observe practical demonstrations of the procedure.
We believe the workshops to be of benefit to any doctor who may in future wish to perform Urolastic procedures.
If you are a specialist and wish to receive training in our procedures please contact us by sending an e-mail to


Urogyn soon on the television channel N1

Last week N1 (local TV-station) visited Urogyn to shoot an interview about Urolastic for the new TV show ‘NIJMEEGSE KENNIS’. The program makers are looking for innovative developments and products with their origin in Nijmegen. The series of 7 or 8 innovative ideas show there are lots of interesting developments going on in Nijmegen.
One of the innovative products showcased in the series will be Urolastic, the minimally-invasive treatment for stress urinary incontinence in women. The series will be broadcast in March and April on N1. When the exact date and time of the broadcast are known, we will announce it here.


Leader Biomedical and Urogyn collaborate to bring innovative new procedure Urolastic™ to India

Amsterdam, The Netherlands- Urogyn B.V. and Leader Biomedical are proud to announce that Urolastic™ – an innovative Urinary Stress incontinence product – has been introduced into the product registration process in India. This marks the first step towards bringing a novel therapeutic solution to patients and caregivers in India.

Many women suffer from Stress Urinary Incontinence (SUI), radically affecting their quality of life due to restraining problems. Their social life is negatively influenced by involuntary leakage during coughing, sneezing, laughing or exercise. Urogyn has developed a product that shares the properties of being injectable, but does not shrink or degrade, thus remaining effective in the longer term. The material will also show up on X-rays and ultrasound, and can be removed if required.

Urolastic™ is an extremely biocompatible rubbery compound that forms in place after injection. The product consists of a dual syringe that is connected to a static mixing tube with a needle. When the dual syringe is compressed, the two components meet and mix in the static mixing tube. The mixed compound is then passed through the needle. This permits small amounts of compound to be placed in the tissue around the urethra. The mixture forms as small flexible balls, which are over time encapsulated in scar tissue.

“Urogyn B.V. has developed a unique, innovative, cost effective, and above all, female friendly procedure for the treatment of urinary incontinence in women. Our product Urolastic™ provides a minimally-invasive treatment, which is performed under local anesthesia and delivers long-lasting improvements to the quality of life of the patient. Through our new partnership with Leader Biomedical we are able to bring this state of the art treatment for Urinary Stress incontinence to the Indian market.” says Martijn Ligtenberg, COO/CFO, Urogyn B.V.

“The collaboration with Urogyn allows us to further increase our downstream value chain and supports our vision to continuously improve global access to next generation healthcare to India. We see great promise for this product here and we are diligently evaluating opportunities to carry the product in the Leader Biomedical network globally. As part of this larger goal, the product is expected to be introduced in India in the lag end of FY 2017”, adds Basil Babychan, Business Director, Leader Biomedical Group.

About Urogyn: Urogyn was founded in 2009 with the ambition of developing new products in the field of urology and gynaecology, based upon a two-component polymer technology. The first products are now used in the treatment of Stress Urinary Incontinence (SUI) for both men and women. More products are expected to be commercially launched in the near future for birth control and treating faecal incontinence (

About Leader Biomedical: Leader Biomedical seeks to become a leader in the supply of biomaterials and surgical implants, improving global markets’ access to next generation technologies, and medical devices (


Urogyn present at the first scientific meeting of The Parisian Institute of the Pelvic floor & Incontinence

The Parisian Institute of Pelvic floor & Incontinence, organizes its first scientific meeting on Saturday 7 January 2017 at the Royal Pavilion in Paris.

The “Parisian Institute of Pelvic floor & Incontinence” is a health association whose main objective is the multidisciplinary management of pelvic floor disorders, health and quality of life of women.

The scientific program covers the treatment of female urinary incontinence, from diagnosis to treatment.

Innovative new techniques and projects will be presented by the speakers and doctors can visit the Urogyn booth where they will be able to see our incontinence products and sign up for training sessions.


Welcome to our new website

Welcome to our new company website. We hope that the new format will allow you to find the information you need more quickly and easily.

We are continuing to update our website with useful information and news regarding our company and products, so please do check back with us for updates.

Please feel free to contact us if you need more information at


Elva Pharma, our new partner in Croatia!

We are pleased to announce that we have entered into an agreement with Elva Pharma which makes them our exclusive distributor in Croatia.
Elva pharma offers the broad knowledge base of highly experienced, “big pharma” trained professionals, which covers all aspects of the pharmaceutical value chain.
We look forward to working with them and supporting them in bringing our innovative products to the Croatian market.
For further information, please visit their website:


Our products soon available in Colombia

To support our growing list of worldwide distributors, we have appointed the company Gilmedica SA to distribute our products in Colombia.

Gilmedica  is a Colombian company, whose headquarters is located in Acopi Yumbo and has commercial and technical offices in major cities throughout the country, dedicated to importing, marketing and distribution of medical devices and equipment, with more than 36 years of experience in the sector.

To find out more please visit their website


New distributor announcement in Slovakia and Czech Republic

Urogyn is pleased to announce that we have signed an agreement with Archie Samuel s.r.o. to have appointed them as our exclusive distributor for Czech Republic and Slovakia. Established in 1995, the company is specialized in services for the health care industry with a focus on distribution of urology, uro-gynaecology and onco-urology products.

We welcome Archie Samuel s.r.o. to our international distributor network and look forward to a fruitful collaboration.